Literature DB >> 16217098

Coxibs and cardiovascular risk.

Michael J Allen, Pamela McLean-Veysey, Isobel Fleming.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16217098      PMCID： PMC1247685          DOI： 10.1503/cmaj.1050119

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra).

Authors:  Jill Cotter; Eric Wooltorton
Journal:  CMAJ       Date:  2005-04-15       Impact factor: 8.262

2.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.